EE291 Psoriasis-Related Work Productivity Improvement from a Phase 4 Real-World Study Interim Analysis of Tildrakizumab in Patients with Moderate to Severe Psoriasis

We report improvement in work productivity and reduced activity impairment from the Week 28 interim analysis of a real-world study of patients with psoriasis treated with tildrakizumab.

Source: Value in Health - June 26, 2022 Category: International Medicine & Public Health Authors: N Bhatia, J Heim, P Beute, M Torres, B Schenkel, SJ Rozzo, JG Vasquez Source Type: research